A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications. - Wikidata - awgldk - TriplyDB

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.

http://www.wikidata.org/entity/Q33286687

about

Scavenger Receptors: Emerging Roles in Cancer Biology and Immunology The haptoglobin-CD163-heme oxygenase-1 pathway for hemoglobin scavenging TWEAK and the progression of renal disease: clinical translation Soluble Fn14 Is Detected and Elevated in Mouse and Human Kidney Disease TNF superfamily: a growing saga of kidney injury modulators.A novel role for tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure.Reduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infection.Evolution of the CD163 family and its relationship to the bovine gamma delta T cell co-receptor WC1.Clinical significance of sCD163 and its possible role in asthma (Review).High serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Inter- not intraindividual differences in sTWEAK levels predict functional deterioration and mortality in patients with dilated cardiomyopathy.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.Genetic ablation of TWEAK augments regeneration and post-injury growth of skeletal muscle in mice.The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.Serum levels of TWEAK and scavenger receptor CD163 in type 1 diabetes mellitus: relationship with cardiovascular risk factors. a case-control study.Inflammatory cytokines and survival factors from serum modulate tweak-induced apoptosis in PC-3 prostate cancer cells.Precision engineering for PRRSV resistance in pigs: Macrophages from genome edited pigs lacking CD163 SRCR5 domain are fully resistant to both PRRSV genotypes while maintaining biological function.Phage display identification of CD100 in human atherosclerotic plaque macrophages and foam cells.Development of an Fn14 agonistic antibody as an anti-tumor agent.HIV-1/HAART-Related Lipodystrophy Syndrome (HALS) Is Associated with Decreased Circulating sTWEAK Levels.Tweak induces proliferation in renal tubular epithelium: a role in uninephrectomy induced renal hyperplasia Ligand-targeted theranostic nanomedicines against cancer Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease.A CCL24-dependent pathway augments eosinophilic airway inflammation in house dust mite-challenged Cd163(-/-) mice TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha.Expression of CD163 prevents apoptosis through the production of granulocyte colony-stimulating factor in meningioma.Identification of CD163 as an antiinflammatory receptor for HMGB1-haptoglobin complexes.CD163 interacts with TWEAK to regulate tissue regeneration after ischaemic injury Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting Is TWEAK a Biomarker for Autoimmune/Chronic Inflammatory Diseases?Soluble TWEAK plasma levels as a novel biomarker of endothelial function in patients with chronic kidney disease.TWEAK/Fn14 Axis: A Promising Target for the Treatment of Cardiovascular Diseases.The Crystal Structure of the Fifth Scavenger Receptor Cysteine-Rich Domain of Porcine CD163 Reveals an Important Residue Involved in Porcine Reproductive and Respiratory Syndrome Virus Infection TNF-like weak inducer of apoptosis aggravates left ventricular dysfunction after myocardial infarction in mice Reduced circulating sTWEAK levels are associated with metabolic syndrome in elderly individuals at high cardiovascular risk.Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis.TWEAK as a target for therapy in systemic lupus erythematosus.Metacaspase-binding peptide inhibits heat shock-induced death in Leishmania (L.) amazonensis

P2860

Q26799114-7479E5EC-6C84-448E-92C9-F81FF81E64C1 Q26864505-2645B61F-F80E-4AE1-B3ED-E897CDD053A4 Q26996775-972E7985-EDD7-4E21-8DC7-4D4F3B8161F7 Q27347256-BAF050FA-3479-4582-BAD4-927136FCDEB8 Q30479123-E24FD1D7-4DBC-4B4E-A65A-40389C5AC635 Q30496163-634725AE-12E5-404A-8E1D-6730F0B5E76A Q31152445-FD034124-4388-443F-9B34-B40A653876F7 Q33605328-9270576A-C7B7-4EB2-81E1-DEC91F1FF237 Q33674640-984C482D-298C-4F6B-ADF0-ED0AA97052FB Q33765551-5E22E4FE-C858-42E9-9EB6-2D8CC76BB190 Q33893843-E7B8A366-2C16-401A-99BD-23DDBDC65C3B Q33916381-6D3B2D2F-A1EE-479D-9686-3D8B34611A2A Q34162346-4FF3AF9C-C2B8-453F-AF1F-13B9066DDA00 Q34171150-3B6A80CB-50AC-4ED6-8653-9B91FF04D53A Q34348370-F4F0D0CA-74D4-41EF-B331-12407DCD9DAA Q34399571-02F10629-E862-428D-86F4-96D0AAFE07E4 Q34450860-D6CEEBAF-1D67-4A6E-9C3E-4EF437D956EB Q34551960-5420A349-88D7-49D5-B0A5-1C75FB261507 Q35010086-FDE2DE89-F37A-4963-A7A4-5505524C14F5 Q35556794-7CFD8807-D65D-4D8C-9491-81068A239622 Q35866999-ECCE7D60-7B12-4305-97E6-6934F9832AE4 Q35893298-09347C91-CB8B-4AC7-A2CF-081897632C81 Q35895637-0189E905-4358-4ADB-AEB9-9503C4505103 Q35958888-2F475447-4F4F-42AD-90F8-822562B8DE2F Q36693322-6AEB540D-C56A-4542-B9D7-A8B5C32BC638 Q36749651-0153F465-75D1-4C2D-9585-64A90A320392 Q36943867-4150D138-50E0-41BA-810B-376CB2F06F74 Q36992432-BCA807A7-DF92-4D82-A664-53A9C998775E Q37031812-729B3244-09E6-4614-9EDB-DF5849A5D3C7 Q37071856-E5B1166F-0A04-45D6-B6E5-DBB2FB036C7C Q37135363-215B191E-0A62-4130-8426-94B1874DE4C1 Q37415529-D744D9AA-2377-4314-A1C8-EA663D5BBB4C Q37415728-B6B4C2FA-2F34-43B9-BA10-B45F88FE4976 Q37494039-B1D6E622-1915-414C-A3D2-C94FE2BA873D Q37593186-B10F5F74-A224-4122-AF7E-642E1F703BB7 Q37623761-0EE78448-B4A1-4BA5-A2B7-DB52F7C012ED Q37681640-373814BD-92BE-4609-8383-E1BFCA39C2F8 Q37690660-6270D39B-7519-4D55-8185-FDDBB88C735C Q37722596-6752141C-C72C-4ABF-ABFF-624BF1C02B37 Q37745497-CEED13A3-2EB1-40BE-8349-91B4E1186893

P2860

A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications.

http://www.wikidata.org/entity/Q33286687

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

A previously unrecognized prot ...... ntial biological implications.

@ast

A previously unrecognized prot ...... ntial biological implications.

@en

A previously unrecognized prot ...... ntial biological implications.

@nl

type

label

A previously unrecognized prot ...... ntial biological implications.

@ast

A previously unrecognized prot ...... ntial biological implications.

@en

A previously unrecognized prot ...... ntial biological implications.

@nl

prefLabel

A previously unrecognized prot ...... ntial biological implications.

@ast

A previously unrecognized prot ...... ntial biological implications.

@en

A previously unrecognized prot ...... ntial biological implications.

@nl

P1433

Q33286687-8085C27E-85E0-4FB2-9A00-5AB7C35CC31E

P1476

Q33286687-4174CE0F-E262-492A-BAE2-926932029374

P2093

Q33286687-3559D030-8336-421E-96E8-6E13D6DF70E8

Q33286687-55753443-55D2-4E97-896C-C259227825BA

Q33286687-6205CB1E-F6F5-4BB6-A387-21C3284EE1A9

Q33286687-7EE774B9-BE25-4E4A-9427-9E5A8AE708E1

Q33286687-846B3DEF-FA1F-4E14-933A-652F978A95AE

Q33286687-BB9E3A05-85DB-4555-91F7-E26422ACB831

Q33286687-EBB3A7A5-5177-4784-914B-C9D16E7AC7FF

Q33286687-FFC37B39-92E1-40A6-B8E1-986190BB2858

P304

Q33286687-03E10339-25A2-4B4F-85D8-7C992906F8D6

P31

Q33286687-19DD5A5F-4ED2-48E2-81AE-B61837FE87E3

P356

Q33286687-51BAAED2-2CAB-418B-B081-39656B82E3E2

P407

Q33286687-FDC62068-FB2C-49D0-851D-A161FF99779C

P433

Q33286687-F74E325D-408C-424F-BC49-66755D49246E

P478

Q33286687-DBACC3F8-9751-4DA3-822D-A22D2495F1B9

P50

Q33286687-153E8359-3C5D-4E7F-987E-A7A8E0D9C089

P577

Q33286687-CDFD72F0-14A8-461B-855E-14B18291BEAB

P5875

Q33286687-2DEBD17A-5D05-437F-BFCD-FAA42F076CD6

P698

Q33286687-EDE678EC-B60B-438F-98EC-68F1D493A095

P356

JIMMUNOL.178.12.8183

P1433

Journal of Immunology

P1476

A previously unrecognized prot ...... ntial biological implications.

@en

P2093

Akihiko Kuniyasu

http://www.w3.org/2001/XMLSchema#string

Bharat B Aggarwal

http://www.w3.org/2001/XMLSchema#string

Jessica Sun

http://www.w3.org/2001/XMLSchema#string

Laura C Bover

http://www.w3.org/2001/XMLSchema#string

Marina Cardó-Vila

http://www.w3.org/2001/XMLSchema#string

Motohiro Takeya

http://www.w3.org/2001/XMLSchema#string

Roberto Rangel

http://www.w3.org/2001/XMLSchema#string

Wadih Arap

http://www.w3.org/2001/XMLSchema#string

P304

8183-8194

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.178.12.8183

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P50

Renata Pasqualini

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6287290

http://www.w3.org/2001/XMLSchema#string

P698

17548657

http://www.w3.org/2001/XMLSchema#string